+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Integrated care for methadone maintenance patients with hepatitis C virus infection



Integrated care for methadone maintenance patients with hepatitis C virus infection



Kaohsiung Journal of Medical Sciences 2019



The majority of patients undergoing methadone maintenance treatment (MMT) are neither examined nor treated for hepatitis C virus (HCV) infection. We aimed to evaluate an integrated referral model in the management of HCV among MMT patients. This retrospective study included 390 HCV-infected MMT patients between April 2015 and May 2017. Patients who tested positive for HCV antibodies were referred to a liver clinic by MMT case managers or psychiatrists. Patients who agreed to receive anti-HCV treatment were treated with pegylated interferon and ribavirin. The rate of patient engagement at a liver clinic increased from 14.1% to 58.2% after integrated care. Multiple logistic regression analysis showed that higher education level (odds ratio [OR], 1.62; 95% confidence interval [CI], 1.01-2.60) and elevated ALT level (OR, 4.30; 95% CI, 2.70-6.85) were independently associated with patients who accepted referral. Active drug use (OR, 0.52; 95% CI, 0.31-0.85) was inversely associated with referral acceptance. Of the 112 patients who met the criteria for anti-HCV therapy, 66 (58.9%) were treated with pegylated interferon and ribavirin. Finally, the rate of treatment completion and sustained virological response (SVR) was 65.2% and 54.5%, respectively, among the 66 patients. Treatment completion (OR, 39.67; 95% CI, 7.80-201.62) was found to be the only independent factor associated with SVR achievement. Although integrated care by psychiatrists and hepatologists significantly increased the rates of engagement and acceptance of antiviral treatment for HCV-infected MMT patients, only a minority of MMT patients achieved successful treatment.

(PDF emailed within 0-6 h: $19.90)

Accession: 066783033

Download citation: RISBibTeXText

PMID: 31087764

DOI: 10.1002/kjm2.12086


Related references

Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients. Addiction 103(6): 905-918, 2008

Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection. Substance Use and Misuse 45(4): 496-514, 2010

Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection. Drug and Alcohol Dependence 101(3): 176-182, 2009

Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders. Drug and Alcohol Dependence 153: 286-292, 2016

Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program. Annals of Internal Medicine 111(9): 761-763, 1989

Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment. Journal of Addictive Diseases 21(4): 55-66, 2002

The impact of hepatitis C virus infection on methadone maintenance treatment. Mount Sinai Journal of Medicine, New York 67(5-6): 437-443, 2000

Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction. 92(8): 999-1005, 1997

Psychiatric and substance use disorders among methadone maintenance patients with chronic hepatitis C infection: effects on eligibility for hepatitis C treatment. American Journal on Addictions 20(4): 312-318, 2011

Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy. Drug and Alcohol Dependence 116(1-3): 233-237, 2012

Hepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in China. Asia-Pacific Psychiatry 5(3): 191-196, 2014

Treatment of Hepatitis C infection in stable patients on Methadone Maintenance. Hepatology 36(4 Part 2): 568A, October, 2002

A randomized trial of integrated care for methadone-maintenance patients with co-occurring psychiatric disorders. Drug and Alcohol Dependence 140: E103-E104, 2014

Risk Factors of Hepatitis C Virus Infection in Drug Users From Eleven Methadone Maintenance Treatment Clinics in Xi'an, China. Hepatitis Monthly 14(11): E19601, 2015

High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan. Addictive Behaviors 38(4): 2089-2093, 2013